Performance evaluation of in vitro diagnostic medical devices

This European Standard applies to the performance evaluation of in vitro diagnostic medical devices (IVD MDs) including IVD MDs for self-testing. It specifies the responsibilities and general requirements for the planning, conduct, assessment and documentation of a performance evaluation study by the manufacturer. It does not apply to specific evaluation plans for certain IVD MDs or a specific use.
NOTE   For a selection of publications on specific evaluation plans see Bibliography.
Where a manufacturer maintains a quality system this standard addresses the compliance with "design validation" and "design changes" as described in EN ISO 9001, EN 46001 and EN 928 especially considering the nature and use of IVD MDs.
In particular, this standard applies to IVD MDs to
- show evidence to notified bodies and national authorities by results of a performance evaluation that the IVD MD performs as claimed by the manufacturer,
- establish adequate performance evaluation data originating from appropriate studies or resulting from available literature, and to
- satisfy the requirements of a quality system for design validation.

Leistungsbewertung von In-vitro-Diagnostika

Diese Europäische Norm gilt für die Leistungsbewertung von In-vitro-Diagnostika, einschließlich solcher zur Eigenanwendung. Sie legt die Verantwortlichkeiten und allgemeinen Erfordernisse zur Planung, Durchführung, Auswertung und Dokumentation einer Leistungsbewertungsstudie durch den Hersteller fest. Spezielle Studienpläne für bestimmte In-vitro-Diagnostika oder einen speziellen Gebrauch sind nicht Gegenstand dieser Norm.
ANMERKUNG   Eine Auswahl von Veröffentlichungen über spezielle Studienpläne findet sich in den Literaturhinweisen.
Unterhält ein Hersteller ein Qualitätssicherungssystem, bezieht sich diese Norm auf die Erfüllung der Festlegungen zur "Entwicklungsvalidierung" und "Designänderung" nach EN ISO 9001, EN 46001 und EN 928, wobei die letztgenannte Norm speziell In-vitro-Diagnostika behandelt.
Diese Norm gilt insbesondere für In-vitro-Diagnostika, um
3 für benannte Stellen und nationale Behörden mit den Ergebnissen einer Leistungsbewertung den Nachweis zu erbringen, dass das In-vitro-Diagnostikum die vom Hersteller beschriebenen Anforderungen erfüllt,
3 angemessene Angaben aus den Leistungsbewertungsstudien zu erstellen, die aus geeigneten Studien oder der verfügbaren Literatur gewonnen wurden,
3 die Anforderungen eines Qualitätssicherungssystems zur Entwicklungsvalidierung zu erfüllen.

Evaluation des performances des dispositifs médicaux de diagnostic in vitro

La présente Norme européenne s'applique a l'évaluation des performances des dispositifs médicaux de diagnostic in vitro, y compris ceux utilisés pour l'auto-test. Elle spécifie les responsabilités et les exigences générales relatives a la planification, la conduite, l'estimation et la documentation d'une étude d'évaluation des performances par le fabricant. Elle ne s'applique pas aux plans d'évaluation spécifiques a certains dispositifs ou a un usage particulier.
NOTE   Voir dans la bibliographie une sélection de publications concernant des plans d'évaluation spécifiques.
Si le fabricant applique un systeme qualité, la présente norme permet de satisfaire aux exigences de la « validation de la conception » et des « modifications de la conception » décrites dans l'EN ISO 9001, l'EN 46001 et l'EN 928, surtout en ce qui concerne la nature et l'utilisation des dispositifs médicaux de diagnostic in vitro.
La présente norme s'applique aux dispositifs médicaux de diagnostic in vitro et a pour objet :
3 de démontrer aux organismes notifiés et aux autorités nationales, sur la base des résultats d'une évaluation de performances, que les performances du dispositif correspondent a celles déclarées par le fabricant ;
3 de collecter des données adéquates pour évaluer les performances, a partir d'études appropriées ou d'une documentation disponible ; et
3 de satisfaire aux exigences d'un systeme qualité concernant la validation de la conception.

Ovrednotenje diagnostičnih medicinskih pripomočkov lastnosti in vitro

General Information

Status
Published
Publication Date
31-Oct-2002
Technical Committee
Current Stage
6060 - National Implementation/Publication (Adopted Project)
Start Date
01-Nov-2002
Due Date
01-Nov-2002
Completion Date
01-Nov-2002

Relations

Buy Standard

Standard
EN 13612:2002
English language
15 pages
sale 10% off
Preview
sale 10% off
Preview
e-Library read for
1 day

Standards Content (Sample)

2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.Performance evaluation of in vitro diagnostic medical devicesLWUREvaluation des performances des dispositifs médicaux de diagnostic in vitroLeistungsbewertung von In-vitro-DiagnostikaTa slovenski standard je istoveten z:EN 13612:2002SIST EN 13612:2002en11.100.10In vitro diagnostic test systemsICS:SLOVENSKI
STANDARDSIST EN 13612:200201-november-2002







EUROPEAN STANDARDNORME EUROPÉENNEEUROPÄISCHE NORMEN 13612March 2002ICS 11.100English versionPerformance evaluation of in vitro diagnostic medical devicesDétermination des performances des dispositifs médicauxpour diagnostic in vitroLeistungsbewertung von In-vitro-DiagnostikaThis European Standard was approved by CEN on 5 January 2002.CEN members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for giving this EuropeanStandard the status of a national standard without any alteration. Up-to-date lists and bibliographical references concerning such nationalstandards may be obtained on application to the Management Centre or to any CEN member.This European Standard exists in three official versions (English, French, German). A version in any other language made by translationunder the responsibility of a CEN member into its own language and notified to the Management Centre has the same status as the officialversions.CEN members are the national standards bodies of Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece,Iceland, Ireland, Italy, Luxembourg, Malta, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and United Kingdom.EUROPEAN COMMITTEE FOR STANDARDIZATIONCOMITÉ EUROPÉEN DE NORMALISATIONEUROPÄISCHES KOMITEE FÜR NORMUNGManagement Centre: rue de Stassart, 36
B-1050 Brussels© 2002 CENAll rights of exploitation in any form and by any means reservedworldwide for CEN national Members.Ref. No. EN 13612:2002 E



EN 13612:2002 (E)2ContentspageForeword.3Introduction.41
Scope.52
Terms and definitions.53
General requirements for the performance evaluation.63.1
Responsibilities and resources.63.2
Documentation.73.3
Final assessment and review.74
Organisation of a performance evaluation study.74.1
Preconditions.74.2
Evaluation plan.74.3
Sites and resources.84.4
Basic design information.84.5
Experimental design.94.6
Performance study records.94.7
Observations and unexpected outcomes.104.8
Evaluation report.105
Modifications during the performance evaluation study.106
Re-evaluation.107
Protection and safety of probands.11Annex ZA (informative)
Clauses of this European Standard addressing essential requirementsor other provisions of EU Directives.12Bibliography.13



EN 13612:2002 (E)3ForewordThis document EN 13612:2002 has been prepared by Technical Committee CEN/TC 140 "In vitrodiagnostic medical devices", the secretariat of which is held by DIN.The European Diagnostic Manufacturers Association (EDMA) has contributed to its preparation.This European Standard shall be given the status of a national standard, either by publication of anidentical text or by endorsement, at the latest by September 2002, and conflicting national standardsshall be withdrawn at the latest by September 2002.This document has been prepared under a mandate given to CEN by the European Commission andthe European Free Trade Association, and supports essential requirements of EU Directive(s).For relationship with EU Directive(s), see informative annex ZA, which is an integral part of thisdocument.Annex ZA is for information only.This standard includes a Bibliography.According to the CEN/CENELEC Internal Regulations, the national standards organizations of thefollowing countries are bound to implement this European Standard: Austria, Belgium, CzechRepublic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta,Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom.



EN 13612:2002 (E)4IntroductionDirective 98/79/EC on in vitro diagnostic medical devices (IVD MDs) requires in Annex III, section 3,indent 11 and section 6.1, in Annex IV, section 3.2 c) and in Annex V, section 3, that the manufacturerprovides evidence in his technical documentation that the IVD MD performs as claimed, whether theseclaims are of a technical, analytical or diagnostic nature. Such evidence can be shown by data alreadyavailable to the manufacturer or by scientific literature or by data originating from performanceevaluation studies in a clinical or other appropriate environment in accordance with the intended use.If a performance evaluation study is necessary and appropriate to support performance claims of theIVD MD, this standard describes how the manufacturer can fulfil his obligation to conduct ascientifically sound performance evaluation study. The evaluation plan is adapted to the nature of theIVD MD and its intended use, taking into account the various recommendations given in standards andscientific literature.Considering the broad range of IVD MDs covered by Directive 98/79/EC and taking into account that,up to now, there is no uniformly applicable document, it is the purpose of this standard to present thecommon elements to be considered for a performance evaluation. The applicability of many itemsdescribed will depend on the level of complexity of the IVD MD.At the time of drafting this standard it was envisaged that the European Commission would publish anumber of Common Technical Specifications (CTSs) which would be relevant to Directive 98/79/EC onin vitro diagnostic medical devices. It was further envisaged that these would be referenced in theOfficial Journal of the European Communities. In particular these CTSs will apply to in vitro diagnosticmedical devices falling into list A of annex II of the Directive 98/79/EC and possibly a number of in vitrodiagnostic medical devices in list B of annex II of the same directive. Manufacturers should thereforetake these CTSs into account within the context of Article 5 “Reference to standards”, of the Directive98/79/EC.



EN 13612:2002 (E)51
ScopeThis European Standard applies to the performance evaluation of in vitro diagnostic medical devices(IVD MDs) including IVD MDs for self-testing. It specifies the responsibilities and general requirementsfor the planning, conduct, assessment and documentation of a performance evaluation study by themanufacturer. It does not apply to specific evaluation plans for certain IVD MDs or a specific use.NOTEFor a selection of publications on specific evaluation plans see Bibliography.Where a manufacturer maintains a quality system this standard addresses the compliance with"design validation" and "design changes" as described in EN ISO 9001, EN 46001 and EN 928especially considering the nature and use of IVD MDs.In particular, this standard applies to IVD MDs to- show evidence to notified bodies and national authorities by results of a performance evaluation thatthe IVD MD performs as claimed by the manufacturer,- establish adequate performance evaluation data originating from appropriate studies or resultingfrom available literature, and to- satisfy the requirements of a quality system for design validation.2
Terms and definitionsFor the purposes of this European Standard, the following terms and definitions apply.2.1co-ordinator of a performance evaluation studyperson empowered by the manufacturer with responsibility for the entire performance evaluation studyof an in vitro diagnostic medical device2.2drop outspecimen or proband that had been selected for a performance evaluation study, but cannot beinvestigated as planned2.3evaluation plandescription of a planned performance evaluation study2.4evaluation reportdescription of and conclusions from a performance evaluation study2.5investigatorperson responsible for the execution of the performance evaluation at a certain location2.6lay personindividual who does not have specific medical education[EN ISO 9000:2000, 3.8.5]



EN 13612:2002 (E)62.7performance claimspecification in regard to the performance of an in vitro diagnostic medical device laid down in theinformation supplied by the manufacturer2.8performance evaluationinvestigation of the performance of an in vitro diagnostic medical device based upon data alreadyavailable, scientific literature and/or performance evaluation studies2.9performance evaluation studyinvestigation of an in vitro diagnostic medical device intended to validate the performance claimsunder the anticipated conditions of use2.10performance of an in vitro diagnostic medical deviceset of properties of an in vitro diagnostic medical device related to its suitability for the intendedpurpose2.11performance study recordsdocumentation of the experimental steps during the performance evaluation study and resultsobtained2.12proband of a performance evaluation studyindividual being part of a study in order to obtain specimen(s) with defined characteristics to be usedfor the performance evaluation study2.13tutorperson responsible for the supervision of lay persons involved in the performance evaluation study2.14validationconfirmation , through the provision of objective evidence that the requirements for a specific intendeduse or application have been fulfilledNOTE 1
The term “validated” is used to designate the corresponding status.NOTE 2
The use conditions for validation can be real or simulated.[ISO 9000, 3.8.5]3
General requirements for the performance evaluation3.1
Responsibilities and resourcesThe manufacturer takes the responsibility for the initiation and/or the conduct of a performanceevaluation study. He shall define the responsibility and the interrelation of all personnel who manageand conduct the performance evaluation of IVD MDs, particularly for personnel who need theorganisational freedom and authority to



EN 13612:2002 (E)7a) assess the validity of test results and data already available;b) specify performance claims which shall be further examined or confirmed;c) specify and document the evaluation plan and the test procedures;d) prepare the evaluation report.The manufacturer shall appoint a co-ordinator with overall responsibility of the performance evaluationstudy. The co-ordinator shall himself assure that adequate resources are available. The investigatorshall ensure that the evaluation plan is followed at his location and that the study is appropriatelyreviewed from an ethical point of view.3.2
DocumentationThe documentation of the performance evaluation study shall contain the files relating to clauses 3 to7 of this standard and shall be part of the technical documentation of the IVD MD.3.3
Final assessment and reviewThe co-ordinator shall assess and document which performance claims are met, state whether claimsare not met and give recommendations for corrective actions, where necessary.The responsible management of the manufacturer shall make sure that the results of the performanceevaluation study and the recommendations for corrective actions are carefully considered and properlydocumented before issuing a declaration of conformity.4
Organisation of a performance evaluation study4.1
PreconditionsBefore starting a performance evaluation study it shall be ensured by the co-ordinator thata) the performance claims of the IVD MD which are the subject of the study are specified;b) the IVD MD has been manufactured under controlled production processes and conditions;c) the IVD MD to be evaluated meets the quality control release specifications;d) a sufficient number of samples of the IVD MD can be provided during the entire period of theperformance evaluation study;e) all legal requirements for performance evaluation studies are met;f) the investigator(s) is (are) adequately skilled and trained to conduct the study and the necessaryresources are available.4.2
Evaluation planThe evaluation plan shall state the purpose on scientific, technical or medical grounds, the scope ofthe evaluation, the structure and organization of the study and the number of devices concerned.Defining the objective of the study, the co-ordinator shall have assessed which performance claimsare already verified by data or scientific literature.



EN 13612:2002 (E)8The evaluation plan shall be designed to minimise the requirements for invasive sampling. In the caseof IVD MDs for self-testing it shall be ensured that the evaluation plan is appropriate and acceptable tousers and the information provided shall be clear and easily understood.The evaluation plan shall specifya) that the investigator(s) is (are) adequately skilled and trained to use the IVD MD;b) the list of laboratories or other institutions taking part in the performance evaluation study; for self-testing, the location and number of lay persons involved;c) the time-table;d) the necessary minimum number of probands from whom specimens are collected by invasiveprocedures in order to adequately assess the performance of the IVD MD;e) instructions for use including a description of the conditions of use;f) the performance clai
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.